Your session is about to expire
← Back to Search
Behavioral Intervention for Chronic Disease Prevention
N/A
Waitlist Available
Led By Victoria L Seewaldt
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
Study Summary
This trial tests the EML Program in reducing the risk of chronic diseases among underserved communities. EML is a series of free culturally and linguistically appropriate nutrition and physical activity sessions. The interactive education segment of the EML Program is culturally responsive, and based on the community EML program, and topics will include: nutrition guidelines, reading food labels, recipe modification and healthy food preparation, eating healthy on a budget, chronic diseases information and prevention strategies.
Who is the study for?
The Eat, Move, Live Program is for adults over 18 from underserved communities who can speak and understand English or Spanish. It's designed to help reduce cancer and chronic disease risk by teaching healthy lifestyle habits. Participants must be able to engage in physical activity and agree to group consent.Check my eligibility
What is being tested?
This trial tests the EML Program's effectiveness in promoting better nutrition and increasing physical activity. The program includes culturally tailored educational sessions on diet, exercise, food label reading, recipe modification, budget-friendly healthy eating, and chronic disease prevention.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on education about nutrition and physical activity without medical treatments or drugs involved, there are no direct side effects like those seen with medication. However, changes in diet or exercise might cause discomfort initially.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in attitudes and beliefs as measured by questionnaires from baseline to week 12
Changes in behavior as measured by questionnaires from baseline to week 12
Changes in biomarkers
+12 moreSide effects data
From 2020 Phase 3 trial • 177 Patients • NCT0181707513%
Rash maculo-papular
10%
Skin and subcutaneous tissue disorders - Other, specify
1%
Mucositis oral
1%
Sepsis
1%
Skin ulceration
1%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive care (EML program)Experimental Treatment2 Interventions
Participants attend EML program sessions weekly for 12 weeks including an educational session chronic disease risk reduction via nutrition and physical activity, a physical activity session, and a cooking/taste test demonstration.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Intervention
2021
Completed Phase 4
~3740
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,113 Total Patients Enrolled
2 Trials studying Diabetes
191 Patients Enrolled for Diabetes
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,320 Total Patients Enrolled
7 Trials studying Diabetes
28,823 Patients Enrolled for Diabetes
Victoria L SeewaldtPrincipal InvestigatorCity of Hope Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not able to participate in physical activity.You agree to group consent at week 1.\nYou can speak and understand English and/or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive care (EML program)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the research still recruiting participants?
"Yes, clinicaltrials.gov attests to this trial's ongoing recruitment process. It was initially posted on March 20th 2018 and has recently been updated as of June 8th 2022. The study is looking for 500 individuals at 1 site."
Answered by AI
How many participants have been enrolled in this experiment thus far?
"Indeed, clinicaltrials.gov attests to the fact that this research is still in need of participants. It was first unveiled on March 20th 2018 and recently amended on June 8th 2022. The researchers are looking for 500 individuals from a single location."
Answered by AI
Who else is applying?
What state do they live in?
Georgia
How old are they?
18 - 65
What site did they apply to?
City of Hope Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How responsive is this trial?
Typically responds via
Email
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger